UA99811U - A method of treating pathogenic induced apoptosis of hepatocytes in alcoholic liver damage - Google Patents
A method of treating pathogenic induced apoptosis of hepatocytes in alcoholic liver damageInfo
- Publication number
- UA99811U UA99811U UAU201414056U UAU201414056U UA99811U UA 99811 U UA99811 U UA 99811U UA U201414056 U UAU201414056 U UA U201414056U UA U201414056 U UAU201414056 U UA U201414056U UA 99811 U UA99811 U UA 99811U
- Authority
- UA
- Ukraine
- Prior art keywords
- hepatocytes
- induced apoptosis
- liver damage
- alcoholic liver
- treating pathogenic
- Prior art date
Links
- 208000022309 Alcoholic Liver disease Diseases 0.000 title abstract 2
- 230000006907 apoptotic process Effects 0.000 title abstract 2
- 210000003494 hepatocyte Anatomy 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000001717 pathogenic effect Effects 0.000 title abstract 2
- RVEWUBJVAHOGKA-WOYAITHZSA-N Arginine glutamate Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RVEWUBJVAHOGKA-WOYAITHZSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000011287 therapeutic dose Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A method of treating pathogenic induced apoptosis of hepatocytes in alcoholic liver damage, comprising administering medicines. A administration for therapeutic purposes hepatoprotector domestic L-arginine, L-glutamate at a rate serednoterapevtychnoyi therapeutic dose ED50 for eleven weeks or more.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201414056U UA99811U (en) | 2014-12-29 | 2014-12-29 | A method of treating pathogenic induced apoptosis of hepatocytes in alcoholic liver damage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201414056U UA99811U (en) | 2014-12-29 | 2014-12-29 | A method of treating pathogenic induced apoptosis of hepatocytes in alcoholic liver damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA99811U true UA99811U (en) | 2015-06-25 |
Family
ID=53675969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201414056U UA99811U (en) | 2014-12-29 | 2014-12-29 | A method of treating pathogenic induced apoptosis of hepatocytes in alcoholic liver damage |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA99811U (en) |
-
2014
- 2014-12-29 UA UAU201414056U patent/UA99811U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023000320A (en) | Methods of modulating drug plasma levels using erythrohydroxybupropion. | |
| MX2021006581A (en) | Bacteria engineered to treat diseases associated with hyperammonemia. | |
| PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
| NZ730809A (en) | Methods for treating filoviridae virus infections | |
| JOP20160092B1 (en) | Treatment of beta thalassemia using a ligne tray | |
| NZ760790A (en) | Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof | |
| MX365939B (en) | Nuclear transport modulators and uses thereof. | |
| PH12017500933A1 (en) | Sublingual administration of riluzole | |
| MX2017006022A (en) | Ornithine aminotransferase inhibition with gaba analogues for treatment of hepatocellular carcinoma. | |
| PH12017500934A1 (en) | Sublingual formulation of riluzole | |
| PH12016502322B1 (en) | Compounds and methods for preventing or treating malaria | |
| MX2018005358A (en) | Optimised high-dose mesalazine-containing tablet. | |
| MX2022013912A (en) | Novel methods for inducing an immune response. | |
| MX2022007315A (en) | Sustained release olanzapine formulations. | |
| MA39743A (en) | Dimethyl fumarate and vaccination regimens | |
| CY1119522T1 (en) | (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| MX2017007245A (en) | Methods of treating fibrosis. | |
| MA39599A (en) | Dosage and administration anti-egfr therapeutics | |
| MY191506A (en) | Dosage regimen for pegylated interferon | |
| MX2020007270A (en) | Parenteral formulation comprising siponimod. | |
| UA99811U (en) | A method of treating pathogenic induced apoptosis of hepatocytes in alcoholic liver damage | |
| IN2013MU03428A (en) | ||
| UA74021U (en) | Method for treating chronic viral hepatitis c | |
| UA91605U (en) | Method for correcting disordered microcirculation in gastric mucosa of aged patients | |
| UA106905U (en) | Pharmaceutical formulation |